Abstract
Although the cognitive and biological characteristics of Alzheimer's disease (AD) are well known and mouse models of AD are available, current treatments for AD-related cognitive deficits have quite limited efficacy. The development of tasks with cross-species validity may enable better prediction of the efficacy of potential new treatments. In this issue of the JCI, Possin et al. present a virtual version of the Morris water maze (a common test of spatial learning and memory for rodents) that is designed for use with humans. The authors tested a mouse model of AD (transgenic mice expressing human amyloid precursor protein [hAPP]) and patients in the earlier mild cognitive impairment (MCI) stage of AD in their respective versions of the maze. Using novel statistical methods, they detected similar deficits across species, providing support for the hAPP model and use of the virtual water maze. Importantly, this work enabled recommendations for appropriate sample sizes when developing potential therapeutics for AD.
References
Dec 3, 1999·British Journal of Clinical Pharmacology·B M McGleenonA P Passmore
Jul 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jorge J PalopLennart Mucke
May 18, 2006·Reviews in the Neurosciences·Neil BurgessLisa Cipolotti
Sep 30, 2006·Neurobiology of Disease·Raphael PoirierM Hasan Mohajeri
May 5, 2007·Science·Erik D RobersonLennart Mucke
Sep 6, 2007·Neurology·A R deIpolyiM L Gorno-Tempini
May 20, 2008·Behavioural Brain Research·Veronica GalvanDale E Bredesen
Oct 22, 2008·Nature Neuroscience·Rene O Sanchez-MejiaLennart Mucke
May 26, 2009·Behavioural Brain Research·Jan LaczóJakub Hort
Jan 8, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Julie A HarrisLennart Mucke
Jun 16, 2010·Neuron·Karen H Ashe, Kathleen R Zahs
Jan 12, 2011·Biochemical Pharmacology·J F Keeler, T W Robbins
Dec 27, 2011·Behavioural Brain Research·Tim KarlBrett Garner
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Zuzana NedelskaJakub Hort
Oct 5, 2013·Neuroscience and Biobehavioral Reviews·Holly MooreDeanna M Barch
Feb 4, 2014·Neuropsychology Review·Maddalena BocciaCecilia Guariglia
May 6, 2014·Frontiers in Genetics·Scott J WebsterLinda J Van Eldik
Dec 18, 2014·Journal of Psychopharmacology·J W Young, M A Geyer
Apr 11, 2015·BMC Medicine·Michael S Rafii, Paul S Aisen
Jan 20, 2016·The Journal of Clinical Investigation·Katherine L PossinSteven Finkbeiner